KI Innovations AB is managing business development within a partnership project for new antibiotics development. This project involves development of an antibiotic that can potentially wipe out the ulcer-causing Helicobacter pylori bacterium. Novo Nordisk Foundation awarded the financing, which KI Innovations won in tough competition. The foundation supports projects in early development phases.